The combined effect of hypertension and type 2 diabetes mellitus on aortic stiffness and endothelial dysfunction: An integrated study with high-resolution MRI

Magnetic Resonance Imaging

Volumn 32, Issue 3, 2014, Pages 211-216

  Shan, Yan ^a   Lin, Jiang ^a   Xu, Pengju ^a   Zeng, Mengsu ^a   Lin, Huandong ^a   Yan, Hongmei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Aortic compliance; Endothelial dysfunction; Hypertension; Magnetic resonance imaging; Type 2 diabetes mellitus

Indexed keywords

AORTIC COMPLIANCE; ENDOTHELIAL DYSFUNCTION; HYPERTENSION; MAGNETIC RESONANCE IMAGING; TYPE 2 DIABETES MELLITUS;

AORTA; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYSTEMS INTEGRATION; VASCULAR STIFFNESS;

EID: 84894245785     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2013.12.011     Document Type: Article

References (27)

1. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787.
2. van der Meer R.W., Diamant M., Westenberg J.J., Doornbos J., Bax J.J., de Roos A., et al. Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus. J Cardiovasc Magn Reson 2007, 9(4):645-651.
3. Naka K.K., Papathanassiou K., Bechlioulis A., Kazakos N., Pappas K., Tigas S., et al. Determinants of vascular function in patients with type 2 diabetes. Cardiovasc Diabetol 2012, 11:127.
4. Cecelja M., Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009, 54(6):1328-1336.
5. Lee J.M., Shirodaria C., Jackson C.E., Robson M.D., Antoniades C., Francis J.M., et al. Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2007, 4(1):44-48.
6. Safar M.E., Levy B.I., Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003, 107(22):2864-2869.
7. Sutton-Tyrrell K., Newman A., Simonsick E.M., Havlik R., Pahor M., Lakatta E., et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001, 38(3):429-433.
8. Lonati C., Morganti A., Comarella L., Mancia G., Zanchetti A., IPERDIA Study Group Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study. J Hypertens 2008, 26(9):1801-1808.
9. Brandts A., van Elderen S.G., Tamsma J.T., Smit J.W., Kroft L.J., Lamb H.J., et al. The effect of hypertension on aortic pulse wave velocity in type-1 diabetes mellitus patients: assessment with MRI. Int J Cardiovasc Imaging 2012, 3(28):543-550.
10. Nigam A., Mitchell G.F., Lambert J., Tardif J.C. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol 2003, 92(4):395-399.
11. Nollen G.J., Westerhof B.E., Groenink M., Osnabrugge A., van der Wall E.E., Mulder B.J. Aortic pressure-area relation in Marfan patients with and without beta blocking agents: a new non-invasive approach. Heart 2004, 90(3):314-318.
12. Ganten M., Krautter U., Hosch W., Hansmann J., von Tengg-Kobligk H., Delorme S., et al. Age related changes of human aortic distensibility: evaluation with ECG-gated CT. Eur Radiol 2007, 17(3):701-708.
13. Shan Y., Lin J., Xu P., Zhou J., Zeng M. Comprehensive assessment of aortic compliance and brachial endothelial function using 3.0-T high-resolution MRI: a feasibility study. J Comput Assist Tomogr 2012, 36(4):437-442.
14. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
15. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112(17):2735-2752.
16. Vulliémoz S., Stergiopulos N., Meuli R. Estimation of local aortic elastic properties with MRI. Magn Reson Med 2002, 47(4):649-654.
17. Beishuizen E.D., Tamsma J.T., Jukema J.W., van de Ree M.A., van der Vijver J.C., Meinders A.E., et al. The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease. Diabetes Care 2005, 28(7):1668-1674.
18. Tsuchiya K., Nakayama C., Iwashima F., Sakai H., Izumiyama H., Doi M., et al. Advanced endothelial dysfunction in diabetic patients with multiple risk factors; importance of insulin resistance. J Atheroscler Thromb 2007, 14(6):303-309.
19. Henry R.M., Ferreira I., Kostense P.J., Dekker J.M., Nijpels G., Heine R.J., et al. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis 2004, 174(1):49-56.
20. Figueiredo V.N., Yugar-Toledo J.C., Martins L.C., Martins L.B., de Faria A.P., de Haro Moraes C., et al. Vascular stiffness and endothelial dysfunction: correlations at different levels of blood pressure. Blood Press 2012, 21(1):31-38.
21. Schalkwijk C.G., Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005, 109(2):143-159.
22. Higashi Y., Kihara Y., Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res 2012, 35(11):1039-1047.
23. Kishi T., Hirooka Y., Konno S., Sunagawa K. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome. J Hypertens 2012, 30(8):1646-1655.
24. Kovacs I., Toth J., Tarjan J., Koller A. Correlation of flow mediated dilation with inflammatory markers in patients with impaired cardiac function. Beneficial effects of inhibition of ACE. Eur J Heart Fail 2006, 8(5):451-459.
25. McEniery C.M., Wallace S., Mackenzie I.S., McDonnell B., Yasmin, Newby D.E., et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006, 48(4):602-608.
26. Protogerou A.D., Papaioannou T.G., Lekakis J.P., Blacher J., Safar M.E. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (Patho)-physiology, rationale and perspective on pulse pressure amplification. Curr Pharm Des 2009, 15(3):267-271.
27. Schmitt M., Avolio A., Qasem A., McEniery C.M., Butlin M., Wilkinson I.B., et al. Basal NO locally modulates human iliac artery function in vivo. Hypertension 2005, 46(1):227-231.